FEB 24, 2016 3:00 PM PST

Bringing precision medicine in oncology to South Africa

Speaker
  • Research Professor Division of Chemical Systems & Synthetic Biology Department of Integrative Biomedical Sciences, University of Cape Town Faculty of Health Sciences
    Biography
      Musa M. Mhlanga (USA citizen), American-born male cell biologist, holds a PhD in cell biology & molecular genetics from New York University School of Medicine (2003). He began his PhD at The Rockefeller University in the laboratory of David Ho where he worked on spectral genotyping of human alleles. He then went on to work on the development of in vitro and in vivo applications of molecular beacons for their use in visualizing RNA in living cells with Fred Russell Kramer and Sanjay Tyagi at New York University School of Medicine. Upon completion of his doctoral work he was awarded a U.S. National Science Foundation post-doctoral fellowship at the Institut Pasteur in Paris, France to work in the laboratory of nuclear cell biology. There he worked on RNA transport and single molecule visualization and tracking of RNA in living cells. In late 2008 he moved his lab to South Africa to join the Council of Scientific and Industrial Research as the Research Leader of the Synthetic Biology Emerging Research Area. He heads the Laboratory for Gene Expression & Biophysics and holds a joint appointment to the Institute of Molecular Medicine in Lisbon, Portugal. His laboratory works on gene regulation, host-pathogen interactions, single molecule imaging of gene expression and the development of cell-based visual high-throughput biology techniques for screening in basic and clinical biology.

    Abstract

    The greatest health epidemic of our time is cancer. Deaths from cancer worldwide outnumber the combined deaths from HIV/AIDS, tuberculosis and malaria by a wide margin. There are at least 100 000 new cases of cancer per year in South Africa ( 2009 numbers, most likely a gross underestimate). The people of Africa, and especially southern Africa, have the greatest degree of genetic diversity in the world. Yet nearly all cancer research occurs outside Africa on non-African patients. Over half of the approximately 8 million deaths from cancer in 2008 occurred in populations in the developing world and this is expected to increase to over two thirds in the next 20 years. As cancer is a molecular disease with a genetic etiology that differs significantly from individual to individual, its treatment has catalyzed the emergence of precision medicine.

    Learning Objectives:
    1.      Describe the importance of african genetic diversity in cancer diagnosis and care
    2.      Describe the benefits are obtained of using "living biobanks" of organoids for drug screening 
     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    Loading Comments...
    Show Resources